CLEVELAND, OH – Seven Ohio oncologists are facing federal charges after allegedly importing cancer medications that skirted FDA approval, the U.S. Attorney’s Office for the Northern District of Ohio announced today. The doctors, practicing across northeast Ohio, stand accused of putting patients at risk by obtaining drugs from sources outside the regulated American supply chain.
The charges center around the importation of drugs including Zometa, Kytril, Taxotere, Gemzar, and Eloxatin. According to the indictment, even if the imported drugs were chemically identical to FDA-approved versions, the lack of proper labeling and inspection constitutes a violation of the Food, Drug, and Cosmetic Act. U.S. Attorney Steven M. Dettelbach made it clear: “These doctors used drugs that had not been approved by the FDA,” and vowed continued commitment to ensuring patient safety through proper drug oversight.
The accused physicians are: Ranjan Bhandari, 56, of Liverpool; Timmappa Bidari, 68, of Parma; David Fishman, 62, of Euclid; Su-Chiao Kuo, 60, of Brunswick; Marwan Massouh, 54, of Westlake; Poornanand Palaparty, 62, of Cleveland; and Hassan Tahsildar, 55, of Euclid. Each faces a misdemeanor charge of causing the shipment of misbranded drugs, a seemingly minor offense that carries potentially serious consequences given the vulnerability of cancer patients.
Antoinette V. Henry, Special Agent in Charge of the FDA’s Office of Criminal Investigations, emphasized the importance of regulatory standards. “FDA’s regulatory standards are designed to ensure the safety and quality of the medical devices and drugs distributed to American consumers,” she stated. “We will continue to work to investigate all persons, including medical professionals, who disregard regulatory requirements and jeopardize the public health by participating in the distribution of misbranded products.” The FDA isn’t just concerned about the drugs themselves, but the entire chain of custody and quality control that’s bypassed when imports aren’t vetted.
If convicted, each doctor faces a maximum sentence of up to one year in prison and fines of up to $100,000. However, Assistant U.S. Attorney Michael L. Collyer, prosecuting the case, noted that sentencing will be determined on a case-by-case basis, taking into account prior criminal record, individual role in the scheme, and other relevant factors. The investigation was a joint effort between the FDA – Office of Criminal Investigations and the Department of Health and Human Services – Office of Inspector General.
Authorities are urging anyone with information regarding healthcare fraud, waste, or abuse to contact the U.S. Department of Health and Human Services, Office of Inspector General at 800-447-8477 or visit www.stopmedicarefraud.gov. It’s crucial to remember that a charge is not proof of guilt, and these doctors are presumed innocent until proven guilty beyond a reasonable doubt in a court of law. Grimy Times will continue to follow this developing story.
Related Federal Cases
Key Facts
- State: Ohio
- Agency: DOJ USAO
- Category: Drug Trafficking|Fraud & Financial Crimes|Violent Crime|Sex Crimes|Cybercrime|Public Corruption|Weapons|Human Trafficking|White Collar Crime|Organized Crime
- Source: Official Source ↗
🔒 Get the grimiest stories delivered weekly. Subscribe free →
Browse More
MORE FEDERAL CRIME NEWS
US NewsUS NewsUS NewsUS News